Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

McKesson
Chubb
Johnson and Johnson
Harvard Business School
Express Scripts
Teva
Mallinckrodt
Julphar
Fuji
Covington

Generated: January 17, 2018

DrugPatentWatch Database Preview

Details for Patent: 4,861,760

« Back to Dashboard

Summary for Patent: 4,861,760
Title: Ophthalmological composition of the type which undergoes liquid-gel phase transition
Abstract:The present invention relates to a pharmaceutical composition intended for contacting with a physiological liquid characterized in that said composition is intended to be administered as a non-gelled liquid form and is intended to gel in situ, this composition containing at least one polysaccharide in aqueous solution, of the type which undergoes liquid-gel phase transition gelling in situ under the effect of an increase in the ionic strength of said physiological liquid.
Inventor(s): Mazuel; Claude (Riom, FR), Friteyre; Marie-Claire (Riom, FR)
Assignee: Merck & Co., Inc. (Rahway, NJ)
Application Number:06/911,606
Patent Claim Types:
see list of patent claims
Composition;

Drugs Protected by US Patent 4,861,760

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Foreign Priority and PCT Information for Patent: 4,861,760

Foriegn Application Priority Data
Foreign Country Foreign Patent Number Foreign Patent Date
France85 14689Oct 03, 1985

International Patents Family Members for US Patent 4,861,760

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Denmark 170500 ➤ Subscribe
European Patent Office 0227494 ➤ Subscribe 95C0013 Belgium ➤ Subscribe
France 2588189 ➤ Subscribe
Greece 862444 ➤ Subscribe
Finland 91217 ➤ Subscribe
Finland 863990 ➤ Subscribe
Spain 2002401 ➤ Subscribe
Denmark 469886 ➤ Subscribe
Cyprus 1779 ➤ Subscribe
China 1046094 ➤ Subscribe
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
US Department of Justice
Johnson and Johnson
Baxter
Covington
Accenture
Moodys
Merck
Mallinckrodt

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot